Huons Global: Shares Down 62.2% Over a Year as Earnings Soften and Disclosure Issues Surface

Thesis

The data supports a picture of a mid-sized pharma company with steady revenue but weaker profitability. Operating margin fell from 15.0% in 2023 to 10.7% in 2025 and 8.1% over the trailing twelve months to H1 2026. The share price has fallen far more than earnings, so multiples have compressed: P/E is 12.4 and P/B is 0.5. Whether the market is pricing in specific concerns is not stated in the data, and no news headlines are available. The data does not show the terms or rationale of the merger decision. Filings show an unfaithful disclosure company designation notice covering the retraction of 3 disclosures, and a withdrawn in-kind dividend plan. These raise questions about governance and communication that the numbers alone cannot answer.

Business overview

Huons Global is listed on KOSDAQ in the Biotech & Pharma sector. It was founded in 1987 and listed in December 2006. Market capitalisation is about ₩279.8B across 12,659,812 listed shares. Revenue grew from ₩579.9B in 2021 to ₩847.5B in 2025, with growth of 14.6% in 2022, 14.2% in 2023, 7.3% in 2024 and 4.2% in 2025. The company is led by Song Soo-young and Yoon Sung-Tae. The data does not describe individual products or business segments.

Model estimate of fair value

Bear

₩27,017

+33%

Base

₩55,862

+175%

Bull

₩105,589

+419%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 7.5%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions

Filings and data used

• Designation of Unfaithful Disclosure Company Notice (Retraction of 3 Disclosures)Sep 23, 2026
• Shareholders' meeting calledAug 26, 2026
• [Correction] Ad Hoc Disclosure Obligation-Related Matters (Fair Disclosure) (Notice of Withdrawal of Plan for In-Kind Dividend to Enhance Shareholder Value)Aug 26, 2026
• Amended: Shareholders' meeting calledAug 26, 2026
• Merger decisionAug 26, 2026
• Amended: Merger decisionAug 26, 2026
• Amended: Notice of shareholders' meetingAug 26, 2026
• Investor relations (IR) eventAug 24, 2026
• Half-year report (Jun 2026)Aug 14, 2026
• Cash dividend decisionAug 11, 2026
• Cash dividend decisionAug 11, 2026
• Decision on Shareholder Register Closure (Record Date) for Interim (Quarterly) DividendAug 11, 2026
• Daily prices up to 2026-10-16
• Financial statements, trailing 12 months as of H1 2026
• Our fair value model, statements as of TTM to H1 2026

Report history

1. Oct 26, 2026Update noteModel fair value changeHuons Global: Model Fair Value Estimate Rises 34.3% on Lower Discount Rate
2. Oct 19, 2026InitiationStart of coverage (reader request)Huons Global: Shares Down 62.2% Over a Year as Earnings Soften and Disclosure Issues Surface